CEL-SCI Corp (CVM) Offering 2M Shares at $2.50

Go back to CEL-SCI Corp (CVM) Offering 2M Shares at $2.50

CEL-SCI Announces Pricing of Public Offering

May 21, 2025 8:14 PM UTC

VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (CEL-SCI or the Company) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $2.50 per share. Total gross proceeds from the offering, before deducting the underwriting discount and other offering expenses, are expected to be $5,000,000. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 190,000 shares to cover over-allotments at the public offering price, less the... More